{
    "organizations": [],
    "uuid": "9be20a798fe182698101a6d3a1a86dc2eea24ba5",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-alteogen-receives-patent/brief-alteogen-receives-patent-idUSL4N1PV1QM",
    "ord_in_thread": 0,
    "title": "BRIEF-Alteogen receives patent",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 5 (Reuters) - Alteogen Inc :\n* Says it receives patent named modified antibody in which motif comprising cysteine residue is bound, modified antibody-drug conjugate comprising the modified antibody, and production\nSource text in Korean: goo.gl/wT5d5s\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-02-05T11:07:00.000+02:00",
    "crawled": "2018-02-05T15:23:39.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "alteogen",
        "inc",
        "say",
        "receives",
        "patent",
        "named",
        "modified",
        "antibody",
        "motif",
        "comprising",
        "cysteine",
        "residue",
        "bound",
        "modified",
        "conjugate",
        "comprising",
        "modified",
        "antibody",
        "production",
        "source",
        "text",
        "korean",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}